Durlobactam, a Diazabicyclooctane β-Lactamase Inhibitor, Inhibits BlaC and Peptidoglycan Transpeptidases of

Mycobacterium tuberculosis durlobactam peptidoglycan transpeptidases β-lactamase inhibitors

Journal

ACS infectious diseases
ISSN: 2373-8227
Titre abrégé: ACS Infect Dis
Pays: United States
ID NLM: 101654580

Informations de publication

Date de publication:
15 Apr 2024
Historique:
medline: 15 4 2024
pubmed: 15 4 2024
entrez: 15 4 2024
Statut: aheadofprint

Résumé

Peptidoglycan synthesis is an underutilized drug target in

Identifiants

pubmed: 38619138
doi: 10.1021/acsinfecdis.4c00119
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Auteurs

Mary Nantongo (M)

Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU), Cleveland, Ohio 44106, United States.
Research Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.

David C Nguyen (DC)

Division of Infectious Diseases, Department of Pediatrics and Division of Infectious Diseases, and Department of Internal Medicine, Rush University Medical Center, Chicago, Illinois 60612, United States.

Christopher R Bethel (CR)

Research Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.

Magdalena A Taracila (MA)

Research Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
Department of Medicine, CWRU, Cleveland, Ohio 44106, United States.

Qing Li (Q)

Department of Medicine, CWRU, Cleveland, Ohio 44106, United States.

Khalid M Dousa (KM)

Research Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.
Department of Medicine, CWRU, Cleveland, Ohio 44106, United States.
Medical Service, Veterans Affairs Northeast Ohio Healthcare System (VANEOHS), Cleveland, Ohio 44106, United States.

Eunjeong Shin (E)

Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU), Cleveland, Ohio 44106, United States.
Research Service, Louis Stokes Veterans Affairs Medical Center, Cleveland, Ohio 44106, United States.

Sebastian G Kurz (SG)

Department of Internal Medicine VIII, Medical Oncology and Pneumology, University of Tübingen, 72076 Tübingen, Germany.

Liem Nguyen (L)

Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU), Cleveland, Ohio 44106, United States.

Barry N Kreiswirth (BN)

Center for Discovery and Innovation, Hackensack, New Jersey 07110, United States.

W Henry Boom (WH)

Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU), Cleveland, Ohio 44106, United States.
Department of Medicine, CWRU, Cleveland, Ohio 44106, United States.
Biopharmaworks, Groton, Connecticut 06340, United States.

Mark S Plummer (MS)

CWRU-Cleveland VAMC Center for Antibiotic Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio 44106, United States.

Robert A Bonomo (RA)

Department of Molecular Biology and Microbiology, Case Western Reserve University (CWRU), Cleveland, Ohio 44106, United States.
Department of Medicine, CWRU, Cleveland, Ohio 44106, United States.
Medical Service, Veterans Affairs Northeast Ohio Healthcare System (VANEOHS), Cleveland, Ohio 44106, United States.
CWRU-Cleveland VAMC Center for Antibiotic Resistance and Epidemiology (Case VA CARES), Cleveland, Ohio 44106, United States.
Departments of Biochemistry, Pharmacology, and Proteomics and Bioinformatics, CWRU, Cleveland, Ohio 44106, United States.
Cleveland Geriatrics Research Education and Clinical Center (GRECC), VANEOHS, Cleveland, Ohio 44106, United States.

Classifications MeSH